Bio-Rad Laboratories Inc Market Cap ($8.27 Billion)
Market Cap & Net Worth: Bio-Rad Laboratories Inc (BIO)
Bio-Rad Laboratories Inc market cap. Bio-Rad Laboratories Inc (NYSE:BIO) has a market capitalization of $8.27 Billion ($8.27 Billion) as of November 8, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #2482 globally and #911 in its home market, demonstrating a -0.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bio-Rad Laboratories Inc's stock price $381.57 by its total outstanding shares 21677137 (21.68 Million). Also see how efficiently does Bio-Rad Laboratories Inc generate cash for how efficiently the company converts equity into cash flow.
Bio-Rad Laboratories Inc Market Cap History (2015–2026)
Bio-Rad Laboratories Inc market cap history from 2015 to 2026. Data shows growth from $3.01 Billion to $8.27 Billion (9.48% CAGR). Check Bio-Rad Laboratories Inc stock quote for real-time trading data and today's change.
Index Memberships
Bio-Rad Laboratories Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Midcap 400
MID
|
$3.26 Trillion | 0.18% | #153 of 401 |
Weight: Bio-Rad Laboratories Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Bio-Rad Laboratories Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bio-Rad Laboratories Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Bio-Rad Laboratories Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.54x
Bio-Rad Laboratories Inc's market cap is 2.54 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.64x
Bio-Rad Laboratories Inc's market cap is 8.64 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.95 Billion | $2.07 Billion | $28.12 Million | 1.91x | 140.49x |
| 2017 | $5.17 Billion | $2.16 Billion | $114.74 Million | 2.40x | 45.09x |
| 2018 | $5.03 Billion | $2.29 Billion | $361.00 Million | 2.20x | 13.94x |
| 2019 | $8.02 Billion | $2.31 Billion | $1.76 Billion | 3.47x | 4.56x |
| 2020 | $12.64 Billion | $2.55 Billion | $3.81 Billion | 4.96x | 3.31x |
| 2021 | $16.38 Billion | $2.92 Billion | $4.25 Billion | 5.60x | 3.85x |
| 2022 | $9.12 Billion | $2.80 Billion | -$3.63 Billion | 3.25x | N/A |
| 2023 | $7.00 Billion | $2.67 Billion | -$637.32 Million | 2.62x | N/A |
| 2024 | $7.12 Billion | $2.57 Billion | -$1.84 Billion | 2.77x | N/A |
| 2025 | $6.57 Billion | $2.58 Billion | $759.90 Million | 2.54x | 8.64x |
Competitor Companies of BIO by Market Capitalization
Companies near Bio-Rad Laboratories Inc in the global market cap rankings as of November 8, 2026. Also see BIO asset base for a full breakdown of the balance sheet.
Key companies related to Bio-Rad Laboratories Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Bio-Rad Laboratories Inc (2015–2026)
Market capitalization of Bio-Rad Laboratories Inc from 2015 to today. Between 2015 and today, Bio-Rad Laboratories Inc's market cap moved from $3.01 Billion to $ 8.27 Billion, with a yearly change of 9.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $8.27 Billion | +25.93% |
| 2025 | $6.57 Billion | -7.77% |
| 2024 | $7.12 Billion | +1.74% |
| 2023 | $7.00 Billion | -23.21% |
| 2022 | $9.12 Billion | -44.35% |
| 2021 | $16.38 Billion | +29.61% |
| 2020 | $12.64 Billion | +57.54% |
| 2019 | $8.02 Billion | +59.34% |
| 2018 | $5.03 Billion | -2.70% |
| 2017 | $5.17 Billion | +30.94% |
| 2016 | $3.95 Billion | +31.46% |
| 2015 | $3.01 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Bio-Rad Laboratories Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.27 Billion USD |
| MoneyControl | $8.27 Billion USD |
| MarketWatch | $8.27 Billion USD |
| marketcap.company | $8.27 Billion USD |
| Reuters | $8.27 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pu… Read more